86 related articles for article (PubMed ID: 24595079)
21. MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer.
Allan JM; Shorto J; Adlard J; Bury J; Coggins R; George R; Katory M; Quirke P; Richman S; Scott D; Scott K; Seymour M; Travis LB; Worrillow LJ; Bishop DT; Cox A; ;
Int J Cancer; 2008 Nov; 123(10):2456-9. PubMed ID: 18712731
[TBL] [Abstract][Full Text] [Related]
22. MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies.
Xu JL; Yin ZQ; Huang MD; Wang XF; Gao W; Liu LX; Wang RS; Huang PW; Yin YM; Liu P; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):901-7. PubMed ID: 22631669
[TBL] [Abstract][Full Text] [Related]
23. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.
Jha R; Gaur P; Sharma SC; Das SN
Gene; 2013 Sep; 526(2):223-7. PubMed ID: 23727610
[TBL] [Abstract][Full Text] [Related]
24. MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.
Sidelnikov E; Bostick RM; Flanders WD; Long Q; Cohen VL; Dash C; Seabrook ME; Fedirko V
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1599-609. PubMed ID: 19423536
[TBL] [Abstract][Full Text] [Related]
25. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer.
Lipkin SM; Rozek LS; Rennert G; Yang W; Chen PC; Hacia J; Hunt N; Shin B; Fodor S; Kokoris M; Greenson JK; Fearon E; Lynch H; Collins F; Gruber SB
Nat Genet; 2004 Jul; 36(7):694-9. PubMed ID: 15184898
[TBL] [Abstract][Full Text] [Related]
26. Single-nucleotide polymorphisms of mismatch repair genes in healthy Chinese individuals and sporadic colorectal cancer patients.
Mei Q; Yan HL; Ding FX; Xue G; Huang JJ; Wang YZ; Sun SH
Cancer Genet Cytogenet; 2006 Nov; 171(1):17-23. PubMed ID: 17074586
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
[TBL] [Abstract][Full Text] [Related]
28. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
[TBL] [Abstract][Full Text] [Related]
29. The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: a meta-analysis.
Pan XM; Yang WZ; Xu GH; Bai P; Qin HJ; Zhang LS; Zhai XD; Tang M; Deng W; Zhang L; Gao LB
Mutagenesis; 2011 Sep; 26(5):667-73. PubMed ID: 21745804
[TBL] [Abstract][Full Text] [Related]
30. Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Hubner RA; Houlston RS
J Natl Cancer Inst; 2007 Oct; 99(19):1490; author reply 1490-1. PubMed ID: 17895478
[No Abstract] [Full Text] [Related]
31. [Mismatch repair gene hMLH1 A655G/A polymorphism and colorectal cancer].
Song L; Zhang XM; Wang DQ; Li JT; Ma GJ; Chen SQ; Zhou JN
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Mar; 13(3):216-8. PubMed ID: 20336543
[TBL] [Abstract][Full Text] [Related]
32. Effect of MLH1 -93G>A on gene expression in patients with colorectal cancer.
Funck A; Santos JC; Silva-Fernandes IJ; Rabenhorst SH; Martinez CA; Ribeiro ML
Med Oncol; 2014 Sep; 31(9):160. PubMed ID: 25115745
[TBL] [Abstract][Full Text] [Related]
33. The MLH1 -93 promoter variant influences gene expression.
Mei M; Liu D; Dong S; Ingvarsson S; Goodfellow PJ; Chen H
Cancer Epidemiol; 2010 Feb; 34(1):93-5. PubMed ID: 20060799
[TBL] [Abstract][Full Text] [Related]
34. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking.
Yu JH; Bigler J; Whitton J; Potter JD; Ulrich CM
Am J Gastroenterol; 2006 Jun; 101(6):1313-9. PubMed ID: 16771955
[TBL] [Abstract][Full Text] [Related]
35. Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity.
Perera S; Mrkonjic M; Rawson JB; Bapat B
Oncol Rep; 2011 Mar; 25(3):809-15. PubMed ID: 21206982
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW;
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764
[TBL] [Abstract][Full Text] [Related]
37. R659X mutation in the MLH1 gene in hereditary non-polyposis colorectal cancer(HNPCC) in an Indian extended family.
Rajender S; Pooja S; Kumar MV; Karwasra R; Singh L; Thangaraj K
Indian J Med Res; 2010 Jan; 131():64-70. PubMed ID: 20167975
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the MLH1 I219V alteration in DNA mismatch repair activity and ulcerative colitis.
Plotz G; Raedle J; Spina A; Welsch C; Stallmach A; Zeuzem S; Schmidt C
Inflamm Bowel Dis; 2008 May; 14(5):605-11. PubMed ID: 18200512
[TBL] [Abstract][Full Text] [Related]
39. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer.
de Vogel S; Bongaerts BW; Wouters KA; Kester AD; Schouten LJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; van Engeland M; Weijenberg MP
Carcinogenesis; 2008 Sep; 29(9):1765-73. PubMed ID: 18339680
[TBL] [Abstract][Full Text] [Related]
40. A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancer.
Middeldorp A; Jagmohan-Changur S; Helmer Q; van der Klift HM; Tops CM; Vasen HF; Devilee P; Morreau H; Houwing-Duistermaat JJ; Wijnen JT; van Wezel T
BMC Cancer; 2007 Jan; 7():6. PubMed ID: 17222328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
